Measurement of the glycaemic index (GI) of an enteral nutrition formulation in healthy subjects - GCOS-010-CE

Fresenius Kabi Deutschland GmbH0 个研究点目标入组 12 人开始时间: 2022年8月18日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Healthy subjects who give informed consent to participate in the study and fulfill the eligibility criteria according to ISO 26642

•- Aged < 18 or > 60 years;
•- Pregnant or lactating;
•- Body mass index (BMI) > 30 kg/m2;
•- Known history of diabetes mellitus or fasting blood glucose value > 6.1 mmol/l or the use of anti-hyperglycaemic drugs or insulin to treat diabetes and related conditions;
•- Any known food allergy or intolerance;
•- Medical condition(s) or medication(s) known to affect glucose regulation, tolerance or appetite and/or which influence digestion and absorption of nutrients (excluding oral contraceptives);
•- Major medical or surgical event requiring hospitalization within the preceding 3 months;
•- Use of steroids, protease inhibitors, amphetamines or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution);
•- Participants who are unable to comply with experimental procedures or do not follow GI testing safety guidelines

发起方